Forgot Password.
By Logging in, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Not a member? Sign Up
By Signing up, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Have an account? Log in
Back to Login? Log in
By registering in, you are agreeing to the MedSearch Global terms and condition and Privacy Policy.
Thinking of joining a study?
Register your interest
5035 results
Interventional
Phase 1
15
INQOVI (decitabine and cedazuridine)
Nivolumab
Case Comprehensive Cancer Center
Source: clinicaltrials.gov
Not Applicable
54
"slump"position
no" slump" position
University Hospital, Rouen
Phase 2
27
Biospecimen Collection
Bone Marrow Biopsy
Computed Tomography
Echocardiography
FDG-Positron Emission Tomography
Glofitamab
Ibrutinib
Magnetic Resonance Imaging
Obinutuzumab
OHSU Knight Cancer Institute
Observational
N/A
15000
No intervention. This is an observational study
Chisquares Incorporated
183
EchoTip AcuCore
Cook Research Incorporated
30
Ladera LBC System
Ladera Medical
400
Simulator-based training
Standard training
Agostino Gemelli University Hospital Foundation IRCCS
240
B U yuan z Hi small formula
Placebo
QingNI
1250
Packaging imagery
No Imagery (Control)
Wake Forest University Health Sciences
116
Caplacizumab
US Thrombotic Microangiopathy Alliance